At a glance
ClinicalIndex Comparison RecordN/ACompleted· 147 enrolled
Drug / intervention
Cormet Hip Resurfacingdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Cormet Hip Resurfacing System Post-PMA Study Group (New Enrollment)
In Brief
A clinical study evaluating Cormet Hip Resurfacing for Osteoarthritis and 2 related conditions. Completed, enrolled 147 participants across 6 sites.
Detailed Summary
The primary objective of this study is to evaluate the performance of the Cormet Hip Resurfacing implant system in the post-approval environment.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsOsteoarthritis, Avascular Necrosis, Rheumatoid Arthritis
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartApr 2008
First PostedJul 2008
Primary CompletionApr 2014
Study CompletionMay 2014
TodayJul 2026
First PostedJul 25, 2008
Enrollment StartApr 24, 2008
Primary CompletionApr 11, 2014
Study CompletionMay 12, 2014
TodayJul 2, 2026
Enrollment to primary: 6.0 yearsPosted 17.9 years ago
Interventions
Cormet Hip Resurfacingdevice
Cormet Hip Resurfacing implant